Copyright
©The Author(s) 2022.
World J Clin Pediatr. Mar 9, 2022; 11(2): 136-150
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.136
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.136
Figure 1 Symptoms and laboratory findings supportive of druggable inborn errors of immunity in various medical specialties.
Figure 2 Some druggable inborn errors of immunities in areas of intersection between more common gnoseological entities: In red druggable inborn errors of immunities and in black common gnoseological entities.
JIA: Juvenile idiopathic arthritis; BD: Bowel disease; A20: A20 haploinsufficiency; HPF: hereditary periodic fever; IBD: Inflammatory bowel disease; CTLA4: Cytotoxic T-Lymphocyte antigen 4; IPEX: Immunodysregulation polyendocrinopathy enteropathy X-linked; LRBA: Lipopolysaccharide-responsive and beige-like anchor protein; STAT1: Signal transducer and activator of transcription 1; SLE: Systemic lupus erythematosus.
Figure 3 A simplified diagram for suspicion and diagnosis of druggable inborn errors of immunity in clinical practice.
- Citation: Boz V, Zanchi C, Levantino L, Riccio G, Tommasini A. Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes. World J Clin Pediatr 2022; 11(2): 136-150
- URL: https://www.wjgnet.com/2219-2808/full/v11/i2/136.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v11.i2.136